Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Disease Models, Animal

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Disease Models, Animal in 55 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
"Acidosis enhances the antitumor effect of melphalan."7.71Acidosis plus melphalan induces nitric oxide-mediated tumor regression in an isolated limb perfusion human melanoma xenograft model. ( Bauer, TW; Buerk, DG; Fraker, DL; Kelley, ST; Menon, C, 2002)
"Both Melatonin and 1400W were efficient in ameliorating experimental I/R injury of the kidneys."5.35Comparison of the efficacy of melatonin and 1400W on renal ischemia/reperfusion injury: a role for inhibiting iNOS. ( Akgul, EO; Cayci, T; Cetiner, S; Ersoz, N; Guven, A; Korkmaz, A; Oztas, E; Turk, E; Uysal, B, 2009)
" In this study, we examined the role of NO in lipopolysaccharide (LPS)-induced inflammation in an ovalbumin (OVA)-challenged mouse asthma model."3.81Nitric oxide suppresses LPS-induced inflammation in a mouse asthma model by attenuating the interaction of IKK and Hsp90. ( Chiang, CP; Huang, CF; Lee, MY; Liu, HY; Sun, GH; Sun, KH; Tang, SJ; Tsou, YC, 2015)
"The present study was designed to investigate the involvement of the nitric oxide (NO)/cyclic guanylate monophosphate pathway in pilocarpine-induced seizures in mice."3.79Involvement of the nitric oxide/cyclic guanylate monophosphate pathway in the pilocarpine-induced seizure model in mice. ( Cavalcante Melo, FH; de Carvalho Lima, CN; de França Fonteles, MM; Freire Vasconcelos, L; Leite Dias, M; Moura Rocha, NF; Rodrigues Carvalho, AM; Soares Lopes, K; Vasconcelos Rios, ER, 2013)
"The administration of a HFD induces insulin resistance in the liver sinusoidal endothelium, which is mediated, at least in part, through iNOS upregulation and can be prevented by the administration of metformin."3.77Insulin resistance and liver microcirculation in a rat model of early NAFLD. ( Abraldes, JG; Bosch, J; García-Pagán, JC; La Mura, V; Pasarín, M; Rodríguez-Vilarrupla, A, 2011)
"Acidosis enhances the antitumor effect of melphalan."3.71Acidosis plus melphalan induces nitric oxide-mediated tumor regression in an isolated limb perfusion human melanoma xenograft model. ( Bauer, TW; Buerk, DG; Fraker, DL; Kelley, ST; Menon, C, 2002)
" It was found that in the carrageenin-induced pleurisy, a single intrapleural injection of the selective inducible NO inhibitors S-(2-aminoethyl) isothiourea (AE-ITU; 3 and 10 mg/kg) and N-(3-(aminomethyl)-benzyl) acetamidine (1400W; 10 mg/kg) or the selective endothelial cell NOS inhibitor L-N(5)(1-iminoethyl)-ornithine (10 mg/kg) not only exacerbated inflammation at the very early stages of the lesion (1-6 h), but also prevented inflammatory resolution."3.71Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration. ( Gilroy, DW; Paul-Clark, MJ; Tomlinson, A; Willis, D; Willoughby, DA, 2001)
"4 mg) caused no significant toxic ocular effects in rabbit eyes."1.46TOWARDS A TREATMENT FOR DIABETIC RETINOPATHY: Intravitreal Toxicity and Preclinical Safety Evaluation of Inducible Nitric Oxide Synthase Inhibitors. ( Bennett, LD; Birch, DG; Carr, BC; Emigh, CE; Nguyen, C; Pansick, AD, 2017)
"Although trauma-hemorrhage produces tissue hypoxia, systemic inflammatory response and organ dysfunction, the mechanisms responsible for these alterations are not clear."1.35Selective inhibition of iNOS attenuates trauma-hemorrhage/resuscitation-induced hepatic injury. ( Bland, KI; Chaudry, IH; Choudhry, MA; Hsu, JT; Kan, WH; Raju, R; Schwacha, MG, 2008)
"1."1.35Effects of 1400W and/or nitroglycerin on renal oxygenation and kidney function during endotoxaemia in anaesthetized rats. ( Dieterich, HJ; Goedhart, PT; Ince, C; Johannes, T; Klingel, K; Mik, EG; Nohé, B; Unertl, KE; Zanke, C, 2009)
"Both Melatonin and 1400W were efficient in ameliorating experimental I/R injury of the kidneys."1.35Comparison of the efficacy of melatonin and 1400W on renal ischemia/reperfusion injury: a role for inhibiting iNOS. ( Akgul, EO; Cayci, T; Cetiner, S; Ersoz, N; Guven, A; Korkmaz, A; Oztas, E; Turk, E; Uysal, B, 2009)
"Treatment of hemodynamic instability in septic shock often demands the administration of vasopressor agents, although these may have deleterious effects on microcirculatory homeostasis."1.33Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock. ( Boer, R; Ghofrani, HA; Grimminger, F; Lehner, M; Maring, D; Mayer, K; Pullamsetti, SS; Rosengarten, B; Schermuly, RT; Schudt, C; Seeger, W; Weissmann, N, 2006)
" These data suggest that the compound has been administered using an appropriate dosing regimen for iNOS inhibition in the rat lung."1.32Pharmacological assessment of the nitric-oxide synthase isoform involved in eosinophilic inflammation in a rat model of sephadex-induced airway inflammation. ( Battram, CH; Belvisi, MG; Birrell, MA; Foster, ML; Haddad, el-B; McCluskie, K; Webber, SE; Yacoub, MH, 2003)

Research

Studies (55)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's32 (58.18)29.6817
2010's20 (36.36)24.3611
2020's3 (5.45)2.80

Authors

AuthorsStudies
Abrams, RPM1
Yasgar, A1
Teramoto, T1
Lee, MH1
Dorjsuren, D1
Eastman, RT1
Malik, N1
Zakharov, AV1
Li, W1
Bachani, M1
Brimacombe, K1
Steiner, JP1
Hall, MD1
Balasubramanian, A1
Jadhav, A1
Padmanabhan, R1
Simeonov, A1
Nath, A1
Hurst, J1
Mueller-Buehl, AM1
Hofmann, L1
Kuehn, S1
Herms, F1
Schnichels, S1
Joachim, SC1
Zhang, Z1
Payne, K1
Pallone, TL1
Staunton, CA1
Barrett-Jolley, R1
Djouhri, L1
Thippeswamy, T3
Wang, B1
Han, S1
Putra, M2
Sharma, S2
Gage, M1
Gasser, G1
Hinojo-Perez, A1
Olson, A1
Gregory-Flores, A1
Puttachary, S2
Wang, C1
Anantharam, V1
Davies, AL1
Desai, RA1
Bloomfield, PS1
McIntosh, PR1
Chapple, KJ1
Linington, C1
Fairless, R1
Diem, R1
Kasti, M1
Murphy, MP1
Smith, KJ1
Chen, TH2
Liao, FT2
Yang, YC2
Wang, JJ2
Wang, J1
Hao, L1
Wang, Y1
Qin, W1
Wang, X1
Zhao, T1
Liu, Y1
Sheng, L1
Du, Y1
Zhang, M1
Lu, Q1
Maher, A1
El-Sayed, NS1
Breitinger, HG1
Gad, MZ1
Verma, S1
Yang, Y2
Thippeswamy, A1
Luo, D1
Carr, BC1
Emigh, CE1
Bennett, LD1
Pansick, AD1
Birch, DG1
Nguyen, C1
Sales, AJ1
Hiroaki-Sato, VA1
Joca, SR1
Kan, WH1
Hsu, JT1
Schwacha, MG1
Choudhry, MA1
Raju, R1
Bland, KI1
Chaudry, IH1
Johannes, T1
Mik, EG1
Klingel, K1
Goedhart, PT1
Zanke, C1
Nohé, B1
Dieterich, HJ1
Unertl, KE1
Ince, C2
Ersoz, N1
Guven, A1
Cayci, T1
Uysal, B1
Turk, E1
Oztas, E1
Akgul, EO1
Korkmaz, A1
Cetiner, S1
Pelaquini, EH1
Guimarães, Lde A1
Benetti, LR1
Fernandes, LG1
Tamashiro, WM1
Conran, N1
Ferreira, HH1
Gao, HM1
Zhang, F1
Zhou, H1
Kam, W1
Wilson, B1
Hong, JS1
Pasarín, M1
Abraldes, JG1
Rodríguez-Vilarrupla, A1
La Mura, V1
García-Pagán, JC1
Bosch, J1
Lewis, CJ1
Cobb, BA1
Souza, FC1
Gobbato, NB1
Maciel, RG1
Prado, CM1
Martins, MA1
Leick, EA1
Tibério, IF1
Vasconcelos Rios, ER1
Moura Rocha, NF1
Rodrigues Carvalho, AM1
Freire Vasconcelos, L1
Leite Dias, M1
de Carvalho Lima, CN1
Soares Lopes, K1
Cavalcante Melo, FH1
de França Fonteles, MM1
Davis, IC1
Zajac, AJ1
Nolte, KB1
Botten, J1
Hjelle, B1
Matalon, S1
Kelley, ST1
Menon, C1
Buerk, DG1
Bauer, TW1
Fraker, DL1
Pittner, A1
Nalos, M1
Asfar, P1
Georgieff, M2
Brückner, UB1
Radermacher, P2
Fröba, G1
Birrell, MA1
McCluskie, K1
Haddad, el-B1
Battram, CH1
Webber, SE1
Foster, ML1
Yacoub, MH1
Belvisi, MG1
Stehr, A1
Ploner, F1
Tugtekin, I1
Matejovic, M1
Theisen, M1
Zülke, C1
Jauch, KW1
Bachetti, T1
Pasini, E1
Suzuki, H1
Ferrari, R1
Price, S1
Mitchell, JA1
Anning, PB1
Evans, TW1
McDonald, M1
Abdelrahman, M1
Cuzzocrea, S1
Thiemermann, C1
Pearse, DD1
Chatzipanteli, K1
Marcillo, AE1
Bunge, MB1
Dietrich, WD1
Slomiany, BL1
Slomiany, A1
Pérez-Asensio, FJ1
Hurtado, O1
Burguete, MC1
Moro, MA2
Salom, JB1
Lizasoain, I2
Torregrosa, G1
Leza, JC2
Alborch, E1
Castillo, J1
Knowles, RG1
Lorenzo, P2
Jafarian-Tehrani, M2
Louin, G2
Royo, NC1
Besson, VC1
Bohme, GA1
Plotkine, M2
Marchand-Verrecchia, C1
Lerouet, D1
Palmier, B1
Bonnefont-Rousselot, D1
Margaill, I1
Mark, LA1
Robinson, AV1
Schulak, JA1
Spiel, AO1
Mayr, FB1
Pullamsetti, SS1
Maring, D1
Ghofrani, HA1
Mayer, K1
Weissmann, N1
Rosengarten, B1
Lehner, M1
Schudt, C1
Boer, R1
Grimminger, F1
Seeger, W1
Schermuly, RT1
Tang, Q1
Svensson, CI1
Fitzsimmons, B1
Webb, M1
Yaksh, TL1
Hua, XY1
Chirino, YI1
Trujillo, J1
Sánchez-González, DJ1
Martínez-Martínez, CM1
Cruz, C1
Bobadilla, NA1
Pedraza-Chaverri, J1
Matsuhisa, S1
Otani, H1
Okazaki, T1
Yamashita, K1
Akita, Y1
Sato, D1
Moriguchi, A1
Imamura, H1
Iwasaka, T1
Paul-Clark, MJ1
Gilroy, DW1
Willis, D1
Willoughby, DA1
Tomlinson, A1
Walpen, S1
Beck, KF1
Schaefer, L1
Raslik, I1
Eberhardt, W1
Schaefer, RM1
Pfeilschifter, J1
Menchén, LA1
Colón, AL1
Menchén, P1
Alvarez, E1
Muijsers, RB1
van Ark, I1
Folkerts, G1
Koster, AS1
van Oosterhout, AJ1
Postma, DS1
Nijkamp, FP1
Krieglstein, CF1
Cerwinka, WH1
Laroux, FS1
Salter, JW1
Russell, JM1
Schuermann, G1
Grisham, MB1
Ross, CR1
Granger, DN1
Sennlaub, F1
Courtois, Y1
Goureau, O1
Lee, MY1
Sun, KH1
Chiang, CP1
Huang, CF1
Sun, GH1
Tsou, YC1
Liu, HY1
Tang, SJ1
Shi, Q1
Liu, X1
Wang, N1
Zheng, X2
Ran, J1
Liu, Z1
Fu, J1
Zheng, J1
Liu, K1
Li, Q1
Zhang, L1
Heusch, P1
Aker, S1
Boengler, K1
Deindl, E1
van de Sand, A1
Klein, K1
Rassaf, T1
Konietzka, I1
Sewell, A1
Menazza, S1
Canton, M1
Heusch, G1
Di Lisa, F1
Schulz, R1
Sigala, F1
Papalambros, E1
Kotsinas, A1
Andreadou, I1
Sigalas, P1
Kremastinos, D1
Bastounis, E1
Gorgoulis, VG1
Robinson, EK1
Kennison, SD1
Suliburk, JW1
Mercer, DW1
Mulè, F1
Zizzo, MG1
Amato, A1
Feo, S1
Serio, R1

Trials

1 trial available for n-(3-(aminomethyl)benzyl)acetamidine and Disease Models, Animal

ArticleYear
Neurological deficits caused by tissue hypoxia in neuroinflammatory disease.
    Annals of neurology, 2013, Volume: 74, Issue:6

    Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental

2013

Other Studies

54 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Disease Models, Animal

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr

2020
iNOS-inhibitor driven neuroprotection in a porcine retina organ culture model.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:7

    Topics: Amacrine Cells; Amidines; Animals; Apoptosis; Benzylamines; Cell Hypoxia; Disease Models, Animal; Hu

2020
Adaptive responses of rat descending vasa recta to ischemia.
    American journal of physiology. Renal physiology, 2018, 03-01, Volume: 314, Issue:3

    Topics: Adaptation, Physiological; Amidines; Angiotensin II; Animals; Arterioles; Benzylamines; Constriction

2018
Inducible nitric oxide synthase inhibition by 1400W limits pain hypersensitivity in a neuropathic pain rat model.
    Experimental physiology, 2018, 04-01, Volume: 103, Issue:4

    Topics: Amidines; Animals; Benzylamines; Cytokines; Disease Models, Animal; Male; Neuralgia; Nitric Oxide; N

2018
Inhibition of Inducible Nitric Oxide Synthase Attenuates Deficits in Synaptic Plasticity and Brain Functions Following Traumatic Brain Injury.
    Cerebellum (London, England), 2018, Volume: 17, Issue:4

    Topics: Amidines; Animals; Benzylamines; Brain; Brain Injuries, Traumatic; Disease Models, Animal; Enzyme In

2018
Inducible nitric oxide synthase inhibitor, 1400W, mitigates DFP-induced long-term neurotoxicity in the rat model.
    Neurobiology of disease, 2020, Volume: 133

    Topics: Amidines; Animals; Benzylamines; Brain; Disease Models, Animal; Enzyme Inhibitors; Isoflurophate; Ma

2020
Inhibition of inducible nitric oxide synthesis ameliorates liver ischemia and reperfusion injury induced transient increase in arterial stiffness.
    Transplantation proceedings, 2014, Volume: 46, Issue:4

    Topics: Amidines; Animals; Benzylamines; Biomarkers; Cytoprotection; Disease Models, Animal; Enzyme Inhibito

2014
Inhibition of inducible nitric oxide synthase ameliorates myocardial ischemia/reperfusion injury - induced acute renal injury.
    Transplantation proceedings, 2014, Volume: 46, Issue:4

    Topics: Acute Kidney Injury; Amidines; Animals; Benzylamines; Biomarkers; Blood Pressure; Cytoprotection; Di

2014
Inhibition of poly (ADP-ribose) polymerase and inducible nitric oxide synthase protects against ischemic myocardial damage by reduction of apoptosis.
    Molecular medicine reports, 2015, Volume: 11, Issue:3

    Topics: Amidines; Animals; Apoptosis; Benzylamines; Cardiotonic Agents; Caspase 3; Disease Models, Animal; E

2015
Overexpression of NMDAR2B in an inflammatory model of Alzheimer's disease: modulation by NOS inhibitors.
    Brain research bulletin, 2014, Volume: 109

    Topics: Alzheimer Disease; Amidines; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal

2014
1400W, a highly selective inducible nitric oxide synthase inhibitor is a potential disease modifier in the rat kainate model of temporal lobe epilepsy.
    Neurobiology of disease, 2016, Volume: 93

    Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; Male;

2016
TOWARDS A TREATMENT FOR DIABETIC RETINOPATHY: Intravitreal Toxicity and Preclinical Safety Evaluation of Inducible Nitric Oxide Synthase Inhibitors.
    Retina (Philadelphia, Pa.), 2017, Volume: 37, Issue:1

    Topics: Amidines; Animals; Aqueous Humor; Benzylamines; Diabetic Retinopathy; Disease Models, Animal; Electr

2017
Participation of hippocampal nitric oxide synthase and soluble guanylate cyclase in the modulation of behavioral responses elicited by the rat forced swimming test.
    Behavioural pharmacology, 2017, Volume: 28, Issue:1

    Topics: Amidines; Animals; Arginine; Benzylamines; Disease Models, Animal; Hippocampus; Male; Nitric Oxide;

2017
Selective inhibition of iNOS attenuates trauma-hemorrhage/resuscitation-induced hepatic injury.
    Journal of applied physiology (Bethesda, Md. : 1985), 2008, Volume: 105, Issue:4

    Topics: Amidines; Animals; Benzylamines; Blood Pressure; Chemokines; Cytokines; Disease Models, Animal; Enzy

2008
Effects of 1400W and/or nitroglycerin on renal oxygenation and kidney function during endotoxaemia in anaesthetized rats.
    Clinical and experimental pharmacology & physiology, 2009, Volume: 36, Issue:9

    Topics: Acute Kidney Injury; Amidines; Anesthesia, General; Animals; Benzylamines; Biomarkers; Creatinine; D

2009
Comparison of the efficacy of melatonin and 1400W on renal ischemia/reperfusion injury: a role for inhibiting iNOS.
    Renal failure, 2009, Volume: 31, Issue:8

    Topics: Amidines; Animals; Antioxidants; Benzylamines; Disease Models, Animal; Enzyme Inhibitors; Kidney; Ki

2009
Role of the Mac-1 and VLA-4 integrins, and concomitant Th2-cytokine production, in nitric oxide modulated eosinophil migration from bone marrow to lungs in allergic mice.
    International immunopharmacology, 2011, Volume: 11, Issue:2

    Topics: Amidines; Animals; Benzylamines; Bone Marrow; Chemotaxis, Leukocyte; Cytokines; Disease Models, Anim

2011
Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.
    Environmental health perspectives, 2011, Volume: 119, Issue:6

    Topics: alpha-Synuclein; Amidines; Animals; Animals, Genetically Modified; Benzylamines; Disease Models, Ani

2011
Insulin resistance and liver microcirculation in a rat model of early NAFLD.
    Journal of hepatology, 2011, Volume: 55, Issue:5

    Topics: Acetylcholine; Amidines; Animals; Benzylamines; Diet, High-Fat; Disease Models, Animal; Endothelium;

2011
Adaptive immune defects against glycoantigens in chronic granulomatous disease via dysregulated nitric oxide production.
    European journal of immunology, 2011, Volume: 41, Issue:9

    Topics: Adaptive Immunity; Adoptive Transfer; Amidines; Animals; Antigen Presentation; Benzylamines; Cells,

2011
Effects of corticosteroid, montelukast and iNOS inhibition on distal lung with chronic inflammation.
    Respiratory physiology & neurobiology, 2013, Jan-15, Volume: 185, Issue:2

    Topics: Acetates; Amidines; Animals; Anti-Inflammatory Agents; Benzylamines; Chronic Disease; Cyclopropanes;

2013
Involvement of the nitric oxide/cyclic guanylate monophosphate pathway in the pilocarpine-induced seizure model in mice.
    Pharmacology, 2013, Volume: 91, Issue:3-4

    Topics: Amidines; Animals; Arginine; Benzylamines; Cyclic GMP; Disease Models, Animal; Enzyme Inhibitors; Gu

2013
Elevated generation of reactive oxygen/nitrogen species in hantavirus cardiopulmonary syndrome.
    Journal of virology, 2002, Volume: 76, Issue:16

    Topics: Adolescent; Adult; Amidines; Animals; Benzylamines; Blood Proteins; Case-Control Studies; Disease Mo

2002
Acidosis plus melphalan induces nitric oxide-mediated tumor regression in an isolated limb perfusion human melanoma xenograft model.
    Surgery, 2002, Volume: 132, Issue:2

    Topics: Acidosis; Amidines; Animals; Antineoplastic Agents, Alkylating; Apoptosis; Benzylamines; Disease Mod

2002
Mechanisms of inducible nitric oxide synthase (iNOS) inhibition-related improvement of gut mucosal acidosis during hyperdynamic porcine endotoxemia.
    Intensive care medicine, 2003, Volume: 29, Issue:2

    Topics: Acidosis; Amidines; Animals; Benzylamines; Blood Gas Analysis; Disease Models, Animal; Drug Evaluati

2003
Pharmacological assessment of the nitric-oxide synthase isoform involved in eosinophilic inflammation in a rat model of sephadex-induced airway inflammation.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 304, Issue:3

    Topics: Amidines; Animals; Benzylamines; Bronchi; Cytokines; Dexamethasone; Dextrans; Disease Models, Animal

2003
Effect of combining nicotinamide as a PARS-inhibitor with selective iNOS blockade during porcine endotoxemia.
    Intensive care medicine, 2003, Volume: 29, Issue:6

    Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy,

2003
Species-specific modulation of the nitric oxide pathway after acute experimentally induced endotoxemia.
    Critical care medicine, 2003, Volume: 31, Issue:5

    Topics: Amidines; Animals; Benzylamines; Blood Pressure; Breath Tests; Disease Models, Animal; Drug Evaluati

2003
Type II nitric oxide synthase activity is cardio-protective in experimental sepsis.
    European journal of pharmacology, 2003, Jul-04, Volume: 472, Issue:1-2

    Topics: Amidines; Animals; Benzylamines; Cardiotonic Agents; Disease Models, Animal; Enzyme Inhibitors; Hear

2003
Tyrphostin reduces the organ injury in haemorrhagic shock: role of inducible nitric oxide synthase.
    Resuscitation, 2003, Volume: 58, Issue:3

    Topics: Amidines; Animals; Benzylamines; Creatine Kinase; Disease Models, Animal; Immunohistochemistry; Kidn

2003
Comparison of iNOS inhibition by antisense and pharmacological inhibitors after spinal cord injury.
    Journal of neuropathology and experimental neurology, 2003, Volume: 62, Issue:11

    Topics: Amidines; Animals; Annexins; Astrocytes; Benzylamines; Blood-Brain Barrier; Cell Count; Cell Death;

2003
Platelet-activating factor mediates Porphyromonas gingivalis lipopolysaccharide interference with salivary mucin synthesis via phosphatidylinositol 3-kinase-dependent constitutive nitric-oxide synthase activation.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2004, Volume: 55, Issue:1 Pt 1

    Topics: Amidines; Androstadienes; Animals; Apoptosis; Benzylamines; Cell Survival; Cells, Cultured; Disease

2004
Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia.
    Neurobiology of disease, 2005, Volume: 18, Issue:2

    Topics: Adenosine Triphosphate; Amidines; Amino Acid Transport System X-AG; Animals; Benzylamines; Brain; Ce

2005
1400W, a potent selective inducible NOS inhibitor, improves histopathological outcome following traumatic brain injury in rats.
    Nitric oxide : biology and chemistry, 2005, Volume: 12, Issue:2

    Topics: Amidines; Animals; Benzylamines; Brain Injuries; Calcium; Disease Models, Animal; Enzyme Inhibitors;

2005
Lack of iNOS induction in a severe model of transient focal cerebral ischemia in rats.
    Experimental neurology, 2005, Volume: 195, Issue:1

    Topics: Amidines; Analysis of Variance; Animals; Anticoagulants; Benzylamines; Blotting, Western; Brain; Cal

2005
Inhibition of nitric oxide synthase reduces renal ischemia/reperfusion injury.
    The Journal of surgical research, 2005, Volume: 129, Issue:2

    Topics: Amidines; Animals; Benzylamines; Creatinine; Disease Models, Animal; Endothelins; Enzyme Inhibitors;

2005
NO-synthase inhibition in sepsis.
    Thrombosis and haemostasis, 2006, Volume: 95, Issue:4

    Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Enzyme Inhibitors; Hemodynamics; Humans; Ni

2006
Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock.
    Thrombosis and haemostasis, 2006, Volume: 95, Issue:4

    Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Enzyme Inhibitors; Epinephrine; Hemoglobins

2006
Inhibition of spinal constitutive NOS-2 by 1400W attenuates tissue injury and inflammation-induced hyperalgesia and spinal p38 activation.
    The European journal of neuroscience, 2007, Volume: 25, Issue:10

    Topics: Amidines; Animals; Benzylamines; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Dr

2007
Selective iNOS inhibition reduces renal damage induced by cisplatin.
    Toxicology letters, 2008, Jan-04, Volume: 176, Issue:1

    Topics: Aldehydes; Amidines; Animals; Antineoplastic Agents; Benzylamines; Cisplatin; Disease Models, Animal

2008
Angiotensin II type 1 receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt-sensitive rat heart.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:6

    Topics: Aldehydes; Amidines; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzylamines; D

2008
Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration.
    Journal of immunology (Baltimore, Md. : 1950), 2001, Jan-15, Volume: 166, Issue:2

    Topics: Acute Disease; Amidines; Animals; Antioxidants; Benzylamines; Carrageenan; Disease Models, Animal; D

2001
Nitric oxide induces MIP-2 transcription in rat renal mesangial cells and in a rat model of glomerulonephritis.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2001, Volume: 15, Issue:3

    Topics: Amidines; Animals; Benzylamines; Chemokine CXCL2; Chemokines; Disease Models, Animal; Enzyme Inhibit

2001
N-(3-(aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats.
    Life sciences, 2001, Jun-15, Volume: 69, Issue:4

    Topics: Amidines; Animals; Benzylamines; Blotting, Western; Colitis; Colon; Disease Models, Animal; Drug Adm

2001
Apocynin and 1400 W prevents airway hyperresponsiveness during allergic reactions in mice.
    British journal of pharmacology, 2001, Volume: 134, Issue:2

    Topics: Acetophenones; Amidines; Animals; Antioxidants; Benzylamines; Bronchial Hyperreactivity; Bronchoalve

2001
Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide.
    The Journal of experimental medicine, 2001, Nov-05, Volume: 194, Issue:9

    Topics: Amidines; Animals; Benzylamines; Colitis, Ulcerative; Colon; Dextran Sulfate; Digestive System; Dige

2001
Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002, May-15, Volume: 22, Issue:10

    Topics: Aging; Amidines; Animals; Animals, Newborn; Apoptosis; Benzylamines; Cell Count; Crosses, Genetic; D

2002
Nitric oxide suppresses LPS-induced inflammation in a mouse asthma model by attenuating the interaction of IKK and Hsp90.
    Experimental biology and medicine (Maywood, N.J.), 2015, Volume: 240, Issue:4

    Topics: Animals; Asthma; Cells, Cultured; Cytokines; Disease Models, Animal; Female; HSP90 Heat-Shock Protei

2015
1400W ameliorates acute hypobaric hypoxia/reoxygenation-induced cognitive deficits by suppressing the induction of inducible nitric oxide synthase in rat cerebral cortex microglia.
    Behavioural brain research, 2017, 02-15, Volume: 319

    Topics: Animals; Annexin A5; Apoptosis; Cells, Cultured; Cognition Disorders; Disease Models, Animal; Gene E

2017
The dynamic detection of NO during stroke and reperfusion in vivo.
    Brain injury, 2009, Volume: 23, Issue:5

    Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Hippocampus; Imines; Indazoles; Infusions, Intra

2009
Increased inducible nitric oxide synthase and arginase II expression in heart failure: no net nitrite/nitrate production and protein S-nitrosylation.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 299, Issue:2

    Topics: Animals; Arginase; Arginine; Blotting, Western; Cardiac Pacing, Artificial; Disease Models, Animal;

2010
Relationship between iNOS expression and aortic cell proliferation and apoptosis in an elastase-induced model of aorta aneurysm and the effect of 1400 W administration.
    Surgery, 2005, Volume: 137, Issue:4

    Topics: Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apoptosis; Cell Division; Disease Models, Ani

2005
Rat gastric injury after lipopolysaccharide: role of inducible nitric oxide synthase.
    Surgery, 2005, Volume: 138, Issue:3

    Topics: Animals; Disease Models, Animal; Female; Gastric Juice; Gastric Mucosa; Imines; Lipopolysaccharides;

2005
Evidence for a role of inducible nitric oxide synthase in gastric relaxation of mdx mice.
    Neurogastroenterology and motility, 2006, Volume: 18, Issue:6

    Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Imines; Male; Mice; Mice, Inbred mdx; Muscle Rel

2006